Herzlich Willkommen auf der Webseite der Klinik für Innere Medizin I am Universitätsklinikum des Saarlandes.

Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls.

Kaddu-Mulindwa D, Thurner L, Bewarder M, Murawski N, Ahlgrimm M, Pfuhl T, Gärtner B, Smola S, Stilgenbauer S.

Infect Agent Cancer. 2021 Feb 24;16(1):17. doi: 10.1186/s13027-021-00356-5. https://pubmed.ncbi.nlm.nih.gov/33627114/

Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis.

Christofyllakis K, Pföhler C, Bewarder M, Müller CSL, Thurner L, Rixecker T, Vogt T, Stilgenbauer S, Yordanova K, Kaddu-Mulindwa D.

Front Oncol. 2021 Feb 18;10:637161. doi: 10.3389/fonc.2020.637161. https://pubmed.ncbi.nlm.nih.gov/33680957/

LRPAP1-autoantibodies in mantle cell lymphoma are associated with superior outcome.

Thurner L, Fadle N, Bittenbring JT, Regitz E, Schuck R, Cetin O, Stuhr A, Rixecker T, Murawski NM, Poeschel V, Kaddu-Mulindwa D, Preuss KD, Stilgenbauer S, Hermine O, Kluin-Nelemans JC, Hartmann S, Dreyling M, Pott C, Bewarder M, Hoster E.

Blood. 2021 Jan 29 https://pubmed.ncbi.nlm.nih.gov/33513604/

Lymphocyte Predominant Cells Detect Moraxella Catarrhalis-Derived Antigens in Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, Evi Regitz, Maria Kemele, Yoo-Jin Kim, Rainer Maria Bohle, Anna Nimmesgern, Lutz von Müller, Volkhard A J Kempf, Marc A Weniger, Frank Neumann, Nadine Schneider, Martine Vornanen, Christer Sundström, Laurence de Leval, Andreas Enger, Dennis A Eichenauer, Ralf Küppers, Klaus-Dieter Preuss, Martin-Leo Hansmann, Michael Pfreundschuh.

Nature Communications. 2020 May 18;11(1):2465. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235000/

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.

Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance.

Lancet 2020 Dec 21;394(10216):2271-2281. https://pubmed.ncbi.nlm.nih.gov/31868632/

LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting.

Thurner L, Hartmann S, Fadle N, Kemele M, Bock T, Bewarder M, Regitz E, Neumann F, Nimmesgern A, von Müller L, Pott C, Kim YJ, Bohle RM, Wasik M, Schuster SJ, Hansmann ML, Preuss KD, Pfreundschuh M.

Leukemia 2019 Jan;33(1):148-158. https://pubmed.ncbi.nlm.nih.gov/29955130/

Venetoclax and Obinutuzumab in Patients With CLL and Coexisting Conditions

Kirsten Fischer , Othman Al-Sawaf , Jasmin Bahlo , Anna-Maria Fink , Maneesh Tandon , Mark Dixon , Sandra Robrecht , Simon Warburton , Kathryn Humphrey , Olga Samoylova , Anna M Liberati , Javier Pinilla-Ibarz , Stephen Opat , Liliya Sivcheva , Katell Le Dû , Laura M Fogliatto , Carsten U Niemann , Robert Weinkove , Sue Robinson , Thomas J Kipps , Sebastian Boettcher , Eugen Tausch , Rod Humerickhouse , Barbara Eichhorst , Clemens-Martin Wendtner , Anton W Langerak , Karl-Anton Kreuzer , Matthias Ritgen , Valentin Goede , Stephan Stilgenbauer , Mehrdad Mobasher , Michael Hallek

N Engl J Med 2019 Jun 6;380(23):2225-2236. https://pubmed.ncbi.nlm.nih.gov/31166681/

Weitere Publikationen...